These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 15121295

  • 1. The evidence for the safety of thiomersal in newborn and infant vaccines.
    Clements CJ.
    Vaccine; 2004 May 07; 22(15-16):1854-61. PubMed ID: 15121295
    [Abstract] [Full Text] [Related]

  • 2. When science is not enough - a risk/benefit profile of thiomersal-containing vaccines.
    Clements CJ, McIntyre PB.
    Expert Opin Drug Saf; 2006 Jan 07; 5(1):17-29. PubMed ID: 16370953
    [Abstract] [Full Text] [Related]

  • 3. [Mercury in vaccines].
    Hessel L.
    Bull Acad Natl Med; 2003 Jan 07; 187(8):1501-10. PubMed ID: 15146581
    [Abstract] [Full Text] [Related]

  • 4. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.
    Pichichero ME, Gentile A, Giglio N, Umido V, Clarkson T, Cernichiari E, Zareba G, Gotelli C, Gotelli M, Yan L, Treanor J.
    Pediatrics; 2008 Feb 07; 121(2):e208-14. PubMed ID: 18245396
    [Abstract] [Full Text] [Related]

  • 5. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
    Heron J, Golding J, ALSPAC Study Team.
    Pediatrics; 2004 Sep 07; 114(3):577-83. PubMed ID: 15342824
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neonate exposure to thimerosal mercury from hepatitis B vaccines.
    Dórea JG, Marques RC, Brandão KG.
    Am J Perinatol; 2009 Aug 07; 26(7):523-7. PubMed ID: 19283656
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neurotoxic character of thimerosal and the allometric extrapolation of adult clearance half-time to infants.
    Magos L.
    J Appl Toxicol; 2003 Aug 07; 23(4):263-9. PubMed ID: 12884410
    [Abstract] [Full Text] [Related]

  • 12. [Thiomersal and immunisations].
    Weisser K, Bauer K, Volkers P, Keller-Stanislawski B.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Dec 07; 47(12):1165-74. PubMed ID: 15583887
    [Abstract] [Full Text] [Related]

  • 13. Modeling neurodevelopment outcomes and ethylmercury exposure from thimerosal-containing vaccines.
    Dórea JG, Marques RC.
    Toxicol Sci; 2008 Jun 07; 103(2):414-5; author reply 416. PubMed ID: 18364366
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Exposure to mercury during the first six months via human milk and vaccines: modifying risk factors.
    Dórea JG.
    Am J Perinatol; 2007 Aug 07; 24(7):387-400. PubMed ID: 17564957
    [Abstract] [Full Text] [Related]

  • 18. An assessment of thimerosal use in childhood vaccines.
    Ball LK, Ball R, Pratt RD.
    Pediatrics; 2001 May 07; 107(5):1147-54. PubMed ID: 11331700
    [Abstract] [Full Text] [Related]

  • 19. Thiomersal as a vaccine preservative.
    Wkly Epidemiol Rec; 2000 Jan 14; 75(2):12-6. PubMed ID: 10697462
    [Abstract] [Full Text] [Related]

  • 20. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.
    Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, Lewis E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, Stewart G, Weintraub ES, Davis RL, DeStefano F, Vaccine Safety Datalink Team.
    N Engl J Med; 2007 Sep 27; 357(13):1281-92. PubMed ID: 17898097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.